NEW YORK (Reuters Health), Sep 18 - The combination of pentoxifylline and vitamin E prevented radiation-induced lymphedema among breast cancer patients in a phase II trial in Sweden.
The finding builds on previous research indicating that pentoxifylline and vitamin E can reverse radiation-induced fibrosis.
In the current study, Dr. Maria Magnusson from Lund University Hospital and colleagues assessed the preventive effects of pentoxifylline added to standard vitamin E therapy on a range of radiation-induced side effects in women with breast cancer treated with surgery followed by radiotherapy.
Starting one to three months after the end of radiotherapy, the 83 participants added either pentoxifylline (400 mg three times daily) or placebo to a 12-month course of vitamin E (100 mg three times daily).
According to a report in the September issue of the European Journal of Cancer, there was no between-group difference in the primary end point -- passive abduction of the shoulder, which improved significantly in both groups, by a median of 3.7° in the pentoxifylline arm and 9.4° in the placebo arm.
The authors do point out that Visual Analogue Score (VAS) for stiffness in the skin, which "may be a harbinger of reduced abduction of the shoulder," fell with pentoxifylline (p = 0.0003) but not with placebo (p = 0.97).
The secondary end point, difference in arm volume, increased over time in the placebo group (1.04%) but not in the pentoxifylline group (0.50%), with a significant difference in favor of pentoxifylline.
Although the study was not designed to show differences in safety, the researchers note that safety was similar in the two groups. Nausea, a well-known transient side-effect of pentoxifylline, was common in pentoxifylline users but had only a small impact in this study. Two patients using the drug discontinued it and one reduced the dose due to nausea.
Magnusson and colleagues conclude that pentoxifylline plus vitamin E can be used "to prevent some radiation-induced side-effects such as the development of increased arm-volume after postoperative irradiation."
Eur J Cancer 2009;45:2488-2495.
Last Updated: 2009-09-18 8:00:16 -0400 (Reuters Health)
Related Reading
Firm promotes BioShield pill to address dose dilemma, September 15, 2009
Study to test radiation protection drug, September 14, 2009
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
